1.
Quaglia FM, Rigolin GM, Saccenti E, Negrini M, Volta E, Dabusti M, Ciccone M, Urso A, Laudisi M, Cuneo A. Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. Mediterr J Hematol Infect Dis [Internet]. 2019Aug.29 [cited 2020Jul.4];11(1):e2019057. Available from: http://mjhid.org/index.php/mjhid/article/view/2019.057